Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Àü¸³¼±¹è´ëÁõ Ä¡·á¿¡¼­ ¾ËÆı³°¨½Å°æÂ÷´ÜÁ¦ÀÎ Terazosin ´Üµ¶¿ä¹ýÀÇ ¹ÝÀÀ ¿¹°ßÁöÇ¥·Î¼­ Àü¸³¼±Æ¯ÀÌÇ׿ø, Àü¸³¼±Àüü¿ëÀû, Àü¸³¼±ÀÌÇà´ë¿ëÀû ¹× Àü¸³¼±ÀÌÇà´ë¿ëÀû Áö¼öÀÇ À¯¿ë¼º Value of Prostate-Specific Antigen, Total Prostate Volume, Transition Zone Volume and Transition Zone Index as the Predictors of Effective Response for Alpha-blocker (Terazosin) Monotherapy in the Management of Benign Prostate Hyperplasia

´ëÇѺñ´¢±â°úÇÐȸÁö 2002³â 43±Ç 10È£ p.842 ~ 846
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú»óÇö/Sang Hyun Park ¼º¶ôÈñ/³ëÃæÈñ/Luck Hee Sung/Choong Hee Noh

Abstract


Benign prostate hyperplasia; Terazosin monotherapy; Transition zone volume; Transition zone index; PSA;

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS